Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02911805 · ClinicalTrials.gov registry record · NA
Bridging Animal and Human Models of Exercise-induced Visual Rehabilitation
A NA study of Vision Disorders, sponsored by VA Office of Research and Development.
- Active
- Registry status
- NA
- Development phase
- 14
- Enrollment target
- 1
- Study location
NCT02911805 is a NA study of Vision Disorders that is active but no longer recruiting, run by VA Office of Research and Development. The registered enrollment target is 14 participants, below the 71-participant average among 5 other Vision Disorders trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02911805, a NA study of Vision Disorders, is active but no longer recruiting, sponsored by VA Office of Research and Development.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will determine whether blood biomarker changes predict sight-saving benefits of exercise.
Conditions Studied
Interventions
- BEHAVIORAL Aerobic exercise
- BEHAVIORAL Balance exercise
Study Locations (1)
Georgia
- Atlanta VA Medical and Rehab Center, Decatur, GA - Decatur
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2015-06-10 |
| Est. Completion | 2028-01-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02911805
The ClinicalTrials.gov registry entry for NCT02911805 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 71-participant average among 5 other Vision Disorders trials with a reported enrollment target (80% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Vision Disorders appearing as the primary indexed condition, and to 2 interventions - of which Aerobic exercise is the first listed.
NCT02911805 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT02911805 about?
NCT02911805 is a clinical study titled "Bridging Animal and Human Models of Exercise-induced Visual Rehabilitation". This study will determine whether blood biomarker changes predict sight-saving benefits of exercise.
What is the current status of trial NCT02911805?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 14 participants. The study started on 2015-06-10. Estimated completion is 2028-01-28.
What conditions does trial NCT02911805 study?
This clinical trial studies the following conditions: Vision Disorders.
What interventions are being tested in trial NCT02911805?
The interventions under investigation include: Aerobic exercise (BEHAVIORAL), Balance exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT02911805?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02911805 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vision Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene
RECRUITING · Phase 2
-
OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity
RECRUITING · Phase 3
-
A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene
ACTIVE NOT RECRUITING · Phase 1
-
A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE)
ACTIVE NOT RECRUITING · Phase 2
-
Natural History Study of CEP290-Related Retinal Degeneration
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.